Aurora Cannabis (ACB) EBITDA Margin (2017 - 2026)
Aurora Cannabis (ACB) posted quarterly EBITDA Margin of 10.88% for Q1 2026, down 743.0% year-over-year from 1.69% in Q1 2025, and down 50.91% quarter-over-quarter from 22.16% in Q4 2025.
Aurora Cannabis (ACB) EBITDA Margin (2017 - 2026) Analysis & Trends
Aurora Cannabis (ACB) has reported EBITDA Margin for 10 consecutive years, with 10.88% the latest figure, recorded in Q1 2026.
- In Q1 2026, EBITDA Margin fell 743.0% year-over-year to 10.88%; the TTM figure through Mar 2026 stood at 9.65% (up 303.0% YoY), while the FY2026 annual figure was 14.55%, down 3422.0% from the prior year.
- EBITDA Margin fell to 10.88% in Q1 2026 per ACB's latest filing, from 22.16% in the prior quarter.
- Across five years, EBITDA Margin topped out at 30.72% in Q4 2024 and bottomed at 1043.86% in Q2 2023.
- Historically, EBITDA Margin has averaged 74.7% across 5 years, with a median of 0.27% in 2022.
- Annual changes were most pronounced in 2023 — EBITDA Margin sank 92397 bps — and 2024, when it soared 104350 bps.
- Aurora Cannabis' EBITDA Margin stood at 0.89% in 2022, then surged by 1127 bps to 10.93% in 2023, then surged by 181 bps to 30.72% in 2024, then decreased by 28 bps to 22.16% in 2025, then sank by 51 bps to 10.88% in 2026.
- Business Quant data shows ACB's EBITDA Margin at 10.88% in Q1 2026, 22.16% in Q4 2025, and 4.34% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.91 Bn | 42.95 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.07 Bn | 39.42 Bn | 2.15 Bn | -5.58% |
| 3 | Zoetis | 31.54 Bn | 29.86 Bn | 1.05 Bn | 33.91% |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn | 16.51% |
| 5 | United Therapeutics | 22.19 Bn | 19.53 Bn | 683.80 Mn | 42.23% |
| 6 | Viatris | 18.68 Bn | 17.79 Bn | 1.46 Bn | 0.17% |
| 7 | Neurocrine Biosciences | 15.50 Bn | 15.11 Bn | 935.80 Mn | 15.80% |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn | 18.13% |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.96 Bn | - | - |
| 10 | Aurora Cannabis | 232.22 Mn | 159.91 Mn | 25.75 Mn | 14.92% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 10.88% |
| Dec 31, 2025 | 22.16% |
| Sep 30, 2025 | 4.34% |
| Jun 30, 2025 | -1.54% |
| Mar 31, 2025 | 18.31% |
| Dec 31, 2024 | 30.72% |
| Sep 30, 2024 | -1.36% |
| Jun 30, 2024 | -0.36% |
| Mar 31, 2024 | 4.64% |
| Dec 31, 2023 | 10.93% |
| Sep 30, 2023 | -1.93% |
| Jun 30, 2023 | -1,043.86% |
| Dec 31, 2022 | 0.89% |
| Sep 30, 2022 | -109.31% |
| Jun 30, 2022 | -119.89% |
| Mar 31, 2022 | -19.86% |
| Dec 31, 2021 | -92.09% |
| Sep 30, 2021 | -20.14% |
| Jun 30, 2021 | 10.45% |
| Mar 31, 2021 | -259.16% |